Search - tctmd.com

Displaying 21 - 40 of 55

Sort: Relevancy | Date

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

News Industry News

Academic Research Organization HCRI Changes Name to The Baim Institute for Clinical Research

October 27, 2016

News Daily News

Timing and Type of Events Post-PCI Have Implications for Prognosis—and Honest Discussions With Patients

Yael L. Maxwell

July 05, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Daily News

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

Yael L. Maxwell

May 02, 2016

News Daily News

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

Yael L. Maxwell

May 02, 2016

News Conference News TCT 2015

Very Late Stent Thrombosis Remains an Important Clinical Target

October 12, 2015

Presentation TCT 2015

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Presenter: Robert A. Byrne, Stefan K. James, Donald Cutlip

October 11, 2015

Presentation TCT 2014

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Louis B. Jacques

September 15, 2014

Presentation TCT 2014

Regulation of Cardiovascular Devices in Europe: A Need for Change

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Angeles Alonso Garcia

September 15, 2014

Presentation TCT 2014

Impact of the Affordable Care Act on Innovation: Effects of the New Reimbursement Climate Change

Presenter: Aaron V. Kaplan, Tamara Syrek Jensen, Donald Cutlip, Jack C. Lewin

September 15, 2014

Presentation TCT 2014

Keynote Lecture III: Updates and Accomplishments of the New CDRH Early Feasibility Program

Presenter: Andrew Farb, Juan F. Granada, Donald Cutlip

September 15, 2014

Presentation TCT 2014

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi, Lisette Okkels Jensen

September 14, 2014

Presentation TCT 2014

State of the (Drug-Eluting) Stent: World-Wide Usage, New Perspectives in Stable CAD, and Remaining Challenges

Presenter: Donald Cutlip, Manel Sabate, Elvin Kedhi

September 14, 2014

Presentation TCT 2014

The Concept of the COBRA PzF-Shielded Stent

Presenter: Renu Virmani, Donald Cutlip

September 13, 2014

News Industry News

CeloNova’s Coronary Stent System Could Mean Faster Healing of Arteries and Greatly Reduced Use of Blood-thinning Medication

March 18, 2014

News Industry News

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

October 30, 2013

Presentation TCT 2013

Implications of Periprocedural CKMB and Troponin Elevations After PCI: A Critical Appraisal

Presenter: Donald Cutlip

October 28, 2013

News Conference News TCT 2012

No Excess Bleeding with EES vs. BMS in Octogenarians Despite Prolonged DAPT

October 26, 2012

Advertisement

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Academic Research Organization HCRI Changes Name to The Baim Institute for Clinical Research

Timing and Type of Events Post-PCI Have Implications for Prognosis—and Honest Discussions With Patients

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

CMS 报销滞后拖慢了心脏装置批准过程：瓣膜终点是否应加入试验当中？

Very Late Stent Thrombosis Remains an Important Clinical Target

Are There Differences in the Outcomes of Early, Late, and Very Late Stent Thrombosis?

Keynote Lecture III: Future Challenges CMS Might Anticipate and Solutions They Might Consider

Regulation of Cardiovascular Devices in Europe: A Need for Change

Impact of the Affordable Care Act on Innovation: Effects of the New Reimbursement Climate Change

Keynote Lecture III: Updates and Accomplishments of the New CDRH Early Feasibility Program

TCT 641: Improved Safety and Reduction in Stent Thrombosis After Everolimus-Eluting Stents Versus Sirolimus-Eluting Stents in Patients with Coronary Artery Disease: SORT-OUT IV 5-Year Results

State of the (Drug-Eluting) Stent: World-Wide Usage, New Perspectives in Stable CAD, and Remaining Challenges

The Concept of the COBRA PzF-Shielded Stent

CeloNova’s Coronary Stent System Could Mean Faster Healing of Arteries and Greatly Reduced Use of Blood-thinning Medication

Tryton Medical Announces First Results From Pivotal Study of the Tryton Side Branch Stent™ Presented at TCT 2013 Annual Meeting in Late Breaking Clinical Trial Session

Implications of Periprocedural CKMB and Troponin Elevations After PCI: A Critical Appraisal

No Excess Bleeding with EES vs. BMS in Octogenarians Despite Prolonged DAPT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content